Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach
Patient Management During Major Abdominal Surgery: the Impact of a Hemodynamic Approach Oriented to Oxygen Consumption Optimization Compared to Standard Approach Targeting Preload-dependency and a Clinically-guided Strategy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
76 participants
Jun 1, 2018
INTERVENTIONAL
Conditions
Summary
This study compares the actual standard of care with a new protocol to guide hemodynamic optimization during major abdominal surgery, which is more tailored on patient real needs. During general anesthesia metabolic needs of the body are markedly reduced and increase in CO may not be necessary. In addition, excessive fluid administration has been related to worse post-operative outcomes. We divide patients into three groups: the standard treatment group, the NICE protocol group and the intervention group. In this group we use the v-aCO2/CaO2-CvO2 as marker of tissue ability to increase their oxygen consumption in response to increased O2 delivery, and based on this index the administration of fluid. The principal aim is to optimize functional hemodynamics in order to reduce the fluid balance at the end of the surgery.
Eligibility
Inclusion Criteria3
- patients aged > 18 years
- acquisition of written informed consent
- Major abdominal surgery (major gastrointestinal surgery: DCP, gastrectomy, Miles, emicolectomy; gynecologic surgery: oncologic surgery) Surgery times ≥ 3 hours
Exclusion Criteria8
- Absolute contraindication to CVC placement
- pregnant women
- hepatic surgery
- laparoscopic surgery
- Major vascular surgery
- Dialysis treatment and kidney transplant surgery
- Severe heart failure (EF ≤ 35%)
- Emergency surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
hemodynamic stability will be achieved through exploration of oxygen consumption need of the patient based on CO2gap/CaO2-CvO2 ratio
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03113435